Peter Kamenický

A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial Evaluating the Efficacy of Burosumab, an Anti-FGF23 Antibody, in Adults With X-Linked Hypophosphatemia: Week 24 Primary Analysis

Karl Insogna, Karine Briot, Erik A. Imel et al. · Journal of Bone and Mineral Research · 2018 · 340 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +17

Gigantism and Acromegaly Due to Xq26 Microduplications and <i>GPR101</i> Mutation

Giampaolo Trivellin, Adrian Daly, Fábio R. Faucz et al. · New England Journal of Medicine · 2014 · 339 citations · Full text

Medicine, Endocrinology, Genetics +15

Therapeutic management of hypophosphatemic rickets from infancy to adulthood

Agnès Linglart, Martin Biosse Duplan, Karine Briot et al. · Endocrine Connections · 2014 · 333 citations · Full text

Medicine, Endocrinology, Nutrition +17

Ketoconazole in Cushing's Disease: Is It Worth a Try?

Frédéric Castinetti, Laurence Guignat, Pauline Giraud et al. · The Journal of Clinical Endocrinology & Metabolism · 2014 · 287 citations · Full text

Medicine, Endocrinology, Pharmacology +9

<i>TAC3</i>and<i>TACR3</i>Defects Cause Hypothalamic Congenital Hypogonadotropic Hypogonadism in Humans

Jacques Young, Jérôme Bouligand, Bruno Francou et al. · The Journal of Clinical Endocrinology & Metabolism · 2010 · 245 citations · Full text

Medicine, Endocrinology, Genetics +17